Neurobiological background of Tic disorders

Advances in Biological Psychiatry

Volumn 24, Issue , 2008, Pages 95-117

  Roessner, Veit ^a   Rothenberger, Aribert ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870258810     PISSN: 03787354     EISSN: 16622774     Source Type: Book Series    
DOI: 10.1159/000118519     Document Type: Article

References (201)

1. Bloch MH, Peterson BS, Scahill L, Otka J, Katsovich L, Zhang H, Leckman JF: Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006;160:65-69.
2. Banaschewski T, Woerner W, Rothenberger A: Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: Developmental aspects in children and adolescents. Dev Med Child Neurol 2003;45:700-703.
3. Kirov R, Kinkelbur J, Banaschewski T, Rothenberger A: Sleep patterns in children with attention-deficit/hyperactivity disorder, tic disorder, and comorbidity. J Child Psychol Psychiatry 2007;48:561-570.
4. Rothenberger A, Banaschewski T, Roessner V: Tic-Störungen; in Herpertz-Dahlmann B, Resch F, Schulte-Markwort M, Warnke A (e ds): Entwicklungspsychiatrie, ed 3. Stuttgart, Schattauer, 2008, pp 694-718.
5. Freeman RD: Answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry 2007;16(suppl 1):15-23.
6. Khalifa N, von Knorring AL: Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatry 2006; 45:1346-1353.
7. Rothenberger A, Roessner V, Banaschewski T, Leckman J: Co-existence of Tic disorders and Attention-deficit/hyperactivity disorder - Recent advances in understanding and treatment. Eur Child Adolesc Psychiatry 2007;16(suppl 1):1-4.
8. Roessner V, Becker A, Banaschewski T, Rothenberger A: Executive functions in children with chronic tic disorders with/without ADHD -new insights. Eur Child Adolesc Psychiatry 2007;16(suppl 1):36-44.
9. Roessner V, Becker A, Banaschewski T, Rothenberger A: Psychopathological profile in children with chronic tic disorder and co-existing ADHD: Additive effects. J Abnorm Child Psychol 2007;35:79-85.
10. Banaschewski T, Neale BM, Rothenberger A, Roessner V: Comorbidity of ADHD and tic disorder - conceptual and methodological considerations. Eur Child Adolesc Psychiatry 2007;16(suppl 1): 5-14.
11. Roessner V, Becker A, Banaschewski T, Rothenberger A: Tic disorders and obsessive compulsive disorder: Where is the link? J Neural Transm Suppl 2005;69:69-99.
12. Robertson MM: Mood disorders and Gilles de la Tourette's syndrome: An update on prevalence, etiology, comorbidity, clinical associations, and implications. J Psychosom Res 2006;61:349-358.
13. Hornsey H, Banerjee S, Zeitlin H, Robertson M: The prevalence of Tourette syndrome in 13-14-year-olds in mainstream schools. J Child Psychol Psychiatry 2001;42:1035-1039.
14. Kadesjo B, Gillberg C: Tourette's disorder: Epidemiology and comorbidity in primary school children. J Am Acad Child Adolesc Psychiatry 2000;39: 548-555.
15. Khalifa N, von Knorring AL: Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 2003;45: 315-319.
16. Khalifa N, von Knorring AL: Tourette syndrome and other tic disorders in a total population of children: Clinical assessment and background. Acta Paediatr 2005;94:1608-1614.
17. Kurlan R, McDermott MP, Deeley C, Como PG, Brower C, Eapen S, Andresen EM, Miller B: Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001;57:1383-1388.
18. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R: How common are the 'common' neurologic disorders? Neurology 2007;68:326-337.
19. Robertson MM: Diagnosing Tourette syndrome: Is it a common disorder? J Psychosom Res 2003;55:3-6.
20. Coffey BJ, Biederman J, Geller D, Frazier J, Spencer T, Doyle R, Gianini L, Small A, Frisone DF, Magovcevic M, Stein N, Faraone SV: Reexamining tic persistence and tic-associated impairment in Tourette's disorder: Findings from a naturalistic follow-up study. J Nerv Ment Dis 2004;192:776-780.
21. Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S: Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology 2003;61:936-940.
22. Paschou P, Feng Y, Pakstis AJ, Speed WC, DeMille MM, Kidd JR, Jaghori B, Kurlan R, Pauls DL, Sandor P, Barr CL, Kidd KK: Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region. Am J Hum Genet 2004;75: 545-560.
23. Pauls DL: An update on the genetics of Gilles de la Tourette syndrome. J Psychosom Res 2003;55:7-12.
24. Nee LE, Caine ED, Polinsky RJ, Eldridge R, Ebert MH: Gilles de la Tourette syndrome: Clinical and family study of 50 cases. Ann Neurol 1980;7:41-49.
25. Pauls DL, Cohen DJ, Heimbuch R, Detlor J, Kidd KK: Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Arch Gen Psychiatry 1981;38:1091-1093.
26. Santangelo SL, Pauls DL, Lavori PW, Goldstein JM, Faraone SV, Tsuang MT: Assessing risk for the Tourette spectrum of disorders among first-degree relatives of probands with Tourette syndrome. Am J Med Genet 1996;67:107-116.
27. Pauls DL, Raymond CL, Stevenson JM, Leckman JF: A family study of Gilles de la Tourette syndrome. Am J Hum Genet 1991;48:154-163.
28. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O: Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance. Am J Hum Genet 1996;59:684-693.
29. Hebebrand J, Klug B, Fimmers R, Seuchter SA, Wettke-Schafer R, Deget F, Camps A, Lisch S, Hebebrand K, von Gontard A, Lehmkuhl G, Poustka F, Schmidt M, Baur MP, Remschmidt H: Rates for tic disorders and obsessive compulsive symptomatology in families of children and adolescents with Gilles de la Tourette syndrome. J Psychiatr Res 1997;31:519-530.
30. Eapen V, Pauls DL, Robertson MM: Evidence for autosomal dominant transmission in Tourette's syndrome. United Kingdom cohort study. Br J Psychiatry 1993;162:593-596.
31. Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF: A twin study of Tourette syndrome. Arch Gen Psychiatry 1985;42:815-820.
32. Hyde TM, Aaronson BA, Randolph C, Rickler KC, Weinberger DR: Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 1992; 42:652-658.
33. Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ: Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986;43:1180-1182.
34. Pauls DL, Hurst CR, Kruger SD, Leckman JF, Kidd KK, Cohen DJ: Gilles de la Tourette's syndrome and attention deficit disorder with hyperactivity. Evidence against a genetic relationship. Arch Gen Psychiatry 1986;43:1177-1179.
35. Pauls DL, Pakstis AJ, Kurlan R, Kidd KK, Leckman JF, Cohen DJ, Kidd JR, Como P, Sparkes R: Segregation and linkage analyses of Tourette's syndrome and related disorders. J Am Acad Child Adolesc Psychiatry 1990;29:195-203.
36. Pauls DL: Issues in genetic linkage studies of Tourette syndrome. Phenotypic spectrum and genetic model parameters. Adv Neurol 1992;58: 151-157.
37. Kurlan R, Eapen V, Stern J, McDermott MP, Robertson MM: Bilineal transmission in Tourette's syndrome families. Neurology 1994;44:2336-2342.
38. Hasstedt SJ, Leppert M, Filloux F, van de Wetering BJ, McMahon WM: Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet 1995;57:682-689.
39. Cavallini MC, Pasquale L, Bellodi L, Smeraldi E: Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 1999;88:38-43.
40. Seuchter SA, Hebebrand J, Klug B, Knapp M, Lehmkuhl G, Poustka F, Schmidt M, Remschmidt H, Baur MP: Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome. Genet Epidemiol 2000;18:33-47.
41. Keen-Kim D, Freimer NB: Genetics and epidemiology of Tourette syndrome. J Child Neurol 2006; 21:665-671.
42. Petek E, Schwarzbraun T, Noor A, Patel M, Nakabayashi K, Choufani S, Windpassinger C, Stamenkovic M, Robertson MM, Aschauer HN, Gurling HM, Kroisel PM, Wagner K, Scherer SW, Vincent JB: Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome. Mol Genet Genomics 2007;277:71-81.
43. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LSt, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW: Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005;310:317-320.
44. Deng H, Le WD, Xie WJ, Jankovic J: Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand 2006;114: 400-402.
45. Niesler B, Frank B, Hebebrand J, Rappold G: Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome. Psychiatr Genet 2005;15:303-304.
46. Lee CC, Chou IC, Tsai CH, Wang TR, Li TC, Tsai FJ: Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr Neurol 2005;33:272-276.
47. McMahon WM, Leppert M, Filloux F, van de Wetering BJ, Hasstedt S: Tourette symptoms in 161 related family members. Adv Neurol 1992;58: 159-165.
48. Barr CL, Wigg KG, Pakstis AJ, Kurlan R, Pauls D, Kidd KK, Tsui LC, Sandor P: Genome scan for linkage to Gilles de la Tourette syndrome. Am J Med Genet 1999;88:437-445.
49. Pakstis AJ, Heutink P, Pauls DL, Kurlan R, van de Wetering BJ, Leckman JF, Sandkuyl LA, Kidd JR, Breedveld GJ, Castiglione CM, et al: Progress in the search for genetic linkage with Tourette syndrome: An exclusion map covering more than 50% of the autosomal genome. Am J Hum Genet 1991;48: 281-294.
50. Heutink P, van de Wetering BJ, Breedveld GJ, Oostra BA: Genetic study on Tourette syndrome in The Netherlands. Adv Neurol 1992;58:167-172.
51. Tourette Syndrome Association International Consortium for Genetics: Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007; 80:265-272.
52. Verkerk AJ, Cath DC, van der Linde HC, Both J, Heutink P, Breedveld G, Aulchenko YS, Oostra BA: Genetic and clinical analysis of a large Dutch Gilles de la Tourette family. Mol Psychiatry 2006;11: 954-964.
53. Robertson MM, Cavanna AE: The Gilles de la Tourette syndrome: A principal component factor analytic study of a large pedigree. Psychiatr Genet 2007;17:143-152.
54. Harris K, Singer HS: Tic disorders: Neural circuits, neurochemistry, and neuroimmunology. J Child Neurol 2006;21:678-689.
55. Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF: Tourette syndrome and tic disorders: A decade of progress. J Am Acad Child Adolesc Psychiatry 2007;46:947-968.
56. Wong DF, Singer HS, Brandt J, Shaya E, Chen C, Brown J, Kimball AW, Gjedde A, Dannals RF, Ravert HT, Wilson PD, Wagner HN Jr: D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 1997;38:1243-1247.
57. Yoon DY, Gause CD, Leckman JF, Singer HS: Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis. J Neurol Sci 2007; 255:50-56.
58. Minzer K, Lee O, Hong JJ, Singer HS: Increased prefrontal D2 protein in Tourette syndrome: A postmortem analysis of frontal cortex and striatum. J Neurol Sci 2004;219:55-61.
59. Singer HS, Hahn IH, Moran TH: Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 1991;30:558-562.
60. Serra-Mestres J, Ring H, Costa D: Dopamine transporter binding in Gilles de la Tourette syndrome: A [123I]FP-CIT/SPECT study. Acta Psychiatr Scand 2004;109:140-146.
61. Cheon KA, Ryu YH, Namkoong K, Kim CH, Kim JJ, Lee JD: Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drugnaive children with Tourette's disorder. Psychiatry Res 2004;130:85-95.
62. Yeh CB, Lee CH, Chou YH, Chang CJ, Ma KH, Huang WS: Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults. Nucl Med Commun 2006;27: 779-784.
63. Yeh CB, Lee CS, Ma KH, Lee MS, Chang CJ, Huang WS: Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with (99m)Tc TRODAT-1 imaging. Psychiatry Res 2007;156: 75-82.
64. Wong D, Brasic J, Singer H: Abnormalities of dopamine and serotonin neuroreceptors with PET in Tourette syndrome (abstract 1012.15). Society for Neuroscience 2005.
65. Singer HS, Szymanski S, Giuliano J, Yokoi F, Dogan AS, Brasic JR, Zhou Y, Grace AA, Wong DF: Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry 2002;159:1329-1336.
66. Solanto MV, Arnsten AFT, Castellanos FX: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. Oxford, Oxford University Press, 2001.
67. Gilbert DL, Christian BT, Gelfand MJ, Shi B, Mantil J, Sallee FR: Altered mesolimbocortical and thalamic dopamine in Tourette syndrome. Neurology 2006;67:1695-1697.
68. Heien ML, Wightman RM: Phasic dopamine signaling during behavior, reward, and disease states. CNS Neurol Disord Drug Targets 2006;5:99-108.
69. Hamamura T, Harada T: Unique pharmacological profile of aripiprazole as the phasic component buster. Psychopharmacology (Berl) 2007;191:741-743.
70. Yoo HK, Kim JY, Kim CY: A pilot study of aripiprazole in children and adolescents with Tourette's disorder; J Child Adolesc Psychopharmacol 2006;16: 505-506.
71. Roessner V, Banaschewski T, Rothenberger A: Therapy of tic-disorders (in German). Z Kinder Jugendpsychiatr Psychother 2004;32:245-263.
72. Rothenberger A, Banaschewski T: Tic-Disorders; in Gillberg C, Harrington R, Steinhausen H-C (eds): A Clinician's Handbook of Child and Adolescent Psychiatry. Cambridge, Cambridge University Press, 2006, pp 598-624.
73. Roessner V, Robatzek M, Knapp G, Banaschewski T, Rothenberger A: First-onset tics in patients with attention-deficit-hyperactivity disorder: Impact of stimulants. Dev Med Child Neurol 2006;48: 616-621.
74. Kurlan R: Tourette's syndrome: Are stimulants safe? Curr Neurol Neurosci Rep 2003;3:285-288.
75. Robertson MM, Eapen V: Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome. Clin Neuropharmacol 1992;15:408-425.
76. Anderson GM, Pollak ES, Chatterjee D, Leckman JF, Riddle MA, Cohen DJ: Brain monoamines and amino acids in Gilles de la Tourette's syndrome: A preliminary study of subcortical regions. Arch Gen Psychiatry 1992;49:584-586.
77. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, McDougle CJ, Scahill LD, Ort SI, Pauls DL, et al: Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995;12: 73-86.
78. Leckman JF: Tourette's syndrome. Lancet 2002; 360:1577-1586.
79. Comings DE: Blood serotonin and tryptophan in Tourette syndrome. Am J Med Genet 1990;36: 418-430.
80. Butler IJ, Koslow SH, Seifert WE Jr, Caprioli RM, Singer HS: Biogenic amine metabolism in Tourette syndrome. Ann Neurol 1979;6:37-39.
81. Anderson GM, Pollak ES, Chatterjee D, Leckman JF, Riddle MA, Cohen DJ: Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv Neurol 1992;58:123-133.
82. Singer HS, Hahn IH, Krowiak E, Nelson E, Moran T: Tourette's syndrome: A neurochemical analysis of postmortem cortical brain tissue. Ann Neurol 1990; 27:443-446.
83. Sallee FR, Richman H, Beach K, Sethuraman G, Nesbitt L: Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1996;35:1647-1656.
84. Heinz A, K nable MB, Wolf SS, J ones DW, Gorey JG, Hyde TM, Weinberger DR: Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. Neurology 1998;51:1069-1074.
85. Muller-Vahl K R, M eyer G J, K napp W H, Emrich HM, Gielow P, Brucke T, Berding G: Serotonin transporter binding in Tourette Syndrome. Neurosci Lett 2005;385:120-125.
86. Haugbol S, Pinborg LH, Regeur L, Hansen ES, Bolwig TG, Nielsen FA, Svarer C, Skovgaard LT, Knudsen GM: Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. Int J Neuropsychopharmacol 2007;10:245-252.
87. Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, Schwartz ML, Leckman JF, Vaccarino FM: Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci USA 2005; 102:13307-13312.
88. Muller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM: Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: A 6-week randomized trial. J Clin Psychiatry 2003;64: 459-465.
89. van Wattum PJ, Chappell PB, Zelterman D, Scahill LD, Leckman JF: Patterns of response to acute naloxone infusion in Tourette's syndrome. Mov Disord 2000;15:1252-1254.
90. Alex KD, Pehek EA: Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 2007;113:296-320.
91. Hoekstra PJ, Anderson GM, Limburg PC, Korf J, Kallenberg CG, Minderaa RB: Neurobiology and neuroimmunology of Tourette's syndrome: An update. Cell Mol Life Sci 2004;61:886-898.
92. Hoekstra PJ, Anderson GM, Troost PW, Kallenberg CGM, Minderaa RB: Plasma kynurenine and related measures in tic disorder patients. Eur Child Adolesc Psychiatry 2007;16:71-77.
93. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271.
94. Kurlan R: The PANDAS hypothesis: Losing its bite? Mov Disord 2004;19:371-374.
95. Snider LA, Swedo SE: PANDAS: Current status and directions for research. Mol Psychiatry 2004;9: 900-907.
96. Riedel M, Straube A, Schwarz MJ, Wilske B, Muller N: Lyme disease presenting as Tourette's syndrome. Lancet 1998;351:418-419.
97. Muller N, Riedel M, Blendinger C, Oberle K, Jacobs E, Abele-Horn M: Mycoplasma pneumoniae infection and Tourette's syndrome. Psychiatry Res 2004; 129:119-125.
98. Muller N, Riedel M, Forderreuther S, Blendinger C, Abele-Horn M: Tourette's syndrome and Mycoplasma pneumoniae infection. Am J Psychiatry 2000;157:481-482.
99. Murphy ML, Pichichero ME: Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002;156:356-361.
100. Lougee L, Perlmutter SJ, Nicolson R, Garvey MA, Swedo SE: Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry 2000;39:1120-1126.
101. Swedo SE, Leonard HL, Mittleman BB, Allen AJ, Rapoport JL, Dow SP, Kanter ME, Chapman F, Zabriskie J: Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997;154: 110-112.
102. Mell LK, Davis RL, Owens D: Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005;116:56-60.
103. Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, Swedo SE: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999;354:1153-1158.
104. Garvey MA, Perlmutter SJ, Allen AJ, Hamburger S, Lougee L, Leonard HL, Witowski ME, Dubbert B, Swedo SE: A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999;45:1564-1571.
105. Snider LA, Lougee L, Slattery M, Grant P, Swedo SE: Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005;57:788-792.
106. Singer HS, Loiselle C: PANDAS: A commentary. J Psychosom Res 2003;55:31-39.
107. Luo F, Leckman JF, Katsovich L, Findley D, Grantz H, Tucker DM, Lombroso PJ, King RA, Bessen DE: Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: Relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004; 113:e578-e585.
108. Perrin EM, Murphy ML, Casey JR, Pichichero ME, Runyan DK, Miller WC, Snider LA, Swedo SE: Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 2004;158:848-856.
109. Cardona F, Orefici G: Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 2001;138:71-75.
110. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM: Tourette's syndrome: A cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003;74:602-607.
111. Muller N, Kroll B, Schwarz MJ, Riedel M, Straube A, Lutticken R, Reinert RR, Reineke T, Kuhnemund O: Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res 2001;101:187-193.
112. Wendlandt JT, Grus FH, Hansen BH, Singer HS: Striatal antibodies in children with Tourette's syndrome: Multivariate discriminant analysis of IgG repertoires. J Neuroimmunol 2001;119:106-113.
113. Morshed SA, Parveen S, Leckman JF, Mercadante MT, Bittencourt Kiss MH, Miguel EC, Arman A, Yazgan Y, Fujii T, Paul S, Peterson BS, Zhang H, King RA, Scahill L, Lombroso PJ: Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 2001;50:566-577.
114. Church AJ, Dale RC, Giovannoni G: Anti-basal ganglia antibodies: A possible diagnostic utility in idiopathic movement disorders? Arch Dis Child 2004;89:611-614.
115. Singer HS, Giuliano JD, Hansen BH, Hallett JJ, Laurino JP, Benson M, Kiessling LS: Antibodies against human putamen in children with Tourette syndrome. Neurology 1998;50:1618-1624.
116. Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH: Anti-basal ganglia antibodies in PANDAS. Mov Disord 2004;19:406-415.
117. Martino D, Defazio G, Church AJ, Dale RC, Giovannoni G, Robertson MM, Orth M: Antineuronal antibody status and phenotype analysis in Tourette's syndrome. Mov Disord 2007;22:1424-1429.
118. Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA: Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry 2005;57:667-673.
119. Kawikova I, Leckman JF, Kronig H, Katsovich L, Bessen DE, Ghebremichael M, Bothwell AL: Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: A preliminary study. Biol Psychiatry 2007; 61:273-278.
120. Singer HS, Giuliano JD, Zimmerman AM, Walkup JT: Infection: A stimulus for tic disorders. Pediatr Neurol 2000;22:380-383.
121. Drake ME Jr, Hietter SA, Padamadan H, Bogner JE: Computerized EEG frequency analysis in Gilles de la Tourette syndrome. Clin Electroencephalogr 1991;22:250-253.
122. Krumholz A, Singer HS, Niedermeyer E, Burnite R, Harris K: Electrophysiological studies in Tourette's syndrome. Ann Neurol 1983;14:638-641.
123. Drake ME Jr, Hietter SA, Padamadan H, Bogner JE, Andrews JM, Weate S: Auditory evoked potentials in Gilles de la Tourette syndrome. Clin Electroencephalogr 1992;23:19-23.
124. Johannes S, Kube C, Wieringa BM, Matzke M, Munte TF: Brain potentials and time estimation in humans. Neurosci Lett 1997;231:63-66.
125. Johannes S, Wieringa BM, Nager W, Muller-Vahl KR, Dengler R, Munte TF: Electrophysiological measures and dual-task performance in Tourette syndrome indicate deficient divided attention mechanisms. Eur J Neurol 2001;8:253-260.
126. Johannes S, Wieringa BM, Nager W, Muller-Vahl KR, Dengler R, Munte TF: Excessive action monitoring in Tourette syndrome. J Neurol 2002;249: 961-966.
127. Oades RD, Dittmann-Balcar A, Schepker R, Eggers C, Zerbin D: Auditory event-related potentials (ERPs) and mismatch negativity (MMN) in healthy children and those with attention-deficit or tourette/tic symptoms. Biol Psychol 1996;43:163-185.
128. van Woerkom TC, Roos RA, van Dijk JG: Altered attentional processing of background stimuli in Gilles de la Tourette syndrome: A study in auditory event-related potentials evoked in an oddball paradigm. Acta Neurol Scand 1994;90:116-123.
129. O'Connor K, Lavoie ME, Robert M: Preparation and motor potentials in chronic tic and Tourette syndromes. Brain Cogn 2001;46:224-226.
130. Obeso JA, Rothwell JC, Marsden CD: Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential. J Neurol Neurosurg Psychiatry 1981;44:735-738.
131. Hallett M: Neurophysiology of tics. Adv Neurol 2001;85:237-244.
132. Rothenberger A, Kemmerling S: Bereitschaftspotential in children with multiple tics and Gilles de la Tourette syndrome; in Rothenberger A (ed): Event-Related Potentials in Children: Basic Concepts and Clinical Applications. Amsterdam, Elsevier, 1982, pp 257-270.
133. Rothenberger A, Kostanecka T, Kinkelbur J, Cohrs S, Woerner W, Hajak G: Sleep and Tourette syndrome. Adv Neurol 2001;85:245-259.
134. Papa SM, Artieda J, Obeso JA: Cortical activity preceding self-initiated and externally triggered voluntary movement. Mov Disord 1991;6:217-224.
135. Serrien DJ, Orth M, Evans AH, Lees AJ, Brown P: Motor inhibition in patients with Gilles de la Tourette syndrome: Functional activation patterns as revealed by EEG coherence. Brain 2005;128:116-125.
136. Plessen KJ, Royal JM, Peterson BS: Neuroimaging of tic disorders with co-existing attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 2007;16(suppl 1):60-70.
137. Rothenberger A: The cortical-subcortical interplay in tic disorders; in Stefanis CN, Rabavilas AD, Soldatos CR (eds): Psychiatry in a World Perspective. Amsterdam, Elsevier, 1990, pp 576-581.
138. Gilbert DL, Sallee FR, Zhang J, Lipps TD, Wassermann EM: Transcranial magnetic stimulation-evoked cortical inhibition: A consistent marker of attention-deficit/hyperactivity disorder scores in Tourette syndrome. Biol Psychiatry 2005;57: 1597-1600.
139. Ziemann U, Paulus W, Rothenberger A: Decreased motor inhibition in Tourette's disorder: Evidence from transcranial magnetic stimulation. Am J Psychiatry 1997;154:1277-1284.
140. Moll GH, Wischer S, Heinrich H, Tergau F, Paulus W, Rothenberger A: Deficient motor control in children with tic disorder: Evidence from transcranial magnetic stimulation. Neurosci Lett 1999;272:37-40.
141. Moll GH, Heinrich H, Trott GE, Wirth S, Bock N, Rothenberger A: Children with comorbid attentiondeficit-hyperactivity disorder and tic disorder: Evidence for additive inhibitory deficits within the motor system. Ann Neurol 2001;49:393-396.
142. Gilbert DL: Motor cortex inhibitory function in Tourette syndrome, attention deficit disorder, and obsessive compulsive disorder: Studies using transcranial magnetic stimulation. Adv Neurol 2006;99: 107-114.
143. Moll GH, Heinrich H, Gevensleben H, Rothenberger A: Tic distribution and inhibitory processes in the sensorimotor circuit during adolescence: A cross-sectional TMS study. Neurosci Lett 2006;403:96-99.
144. Spessot AL, Plessen KJ, Peterson BS: Neuroimaging of developmental psychopathologies: The importance of self-regulatory and neuroplastic processes in adolescence. Ann NY Acad Sci 2004;1021: 86-104.
145. Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM, Leckman JF, Gore JC: A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 1998;55:326-333.
146. Swerdlow NR, Karban B, Ploum Y, Sharp R, Geyer MA, Eastvold A: Tactile prepuff inhibition of startle in children with Tourette's syndrome: In search of an 'fMRI-friendly' startle paradigm. Biol Psychiatry 2001;50:578-585.
147. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, Hallett M: Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results. Biol Psychiatry 1996;39:33-41.
148. Swerdlow NR, Braff DL, Geyer MA: Animal models of deficient sensorimotor gating: What we know, what we think we know, and what we hope to know soon. Behav Pharmacol 2000;11:185-204.
149. Heise CA, Wanschura V, Albrecht B, Uebel H, Roessner V, Himpel S, Paulus W, Rothenberger A, Tergau F: Voluntary motor drive (VMD) in Tourette syndrome - evidence for its reduced suppression. J Neural Transm 2007, in press.
150. Georgiou N, Bradshaw JL, Phillips JG: Directed attention in Gilles de la Tourette syndrome. Behav Neurol 1998;11:85-91.
151. Howells D, Georgiou-Karistianis N, Bradshaw J: The ability to orient attention in Gilles de la Tourette syndrome. Behav Neurol 1998;11:205-209.
152. Cohrs S, Rasch T, Altmeyer S, Kinkelbur J, Kostanecka T, Rothenberger A, Ruther E, Hajak G: Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome. J Neurol Neurosurg Psychiatry 2001;70:192-197.
153. Kirov R, Banaschewski T, Uebel H, Kinkelbur J, Rothenberger A: REM-sleep alterations in children with co-existence of tic disorders and attentiondeficit/hyperactivity disorder: Impact of hypermotor symptoms. Eur Child Adolesc Psychiatry 2007;16(suppl I):I/45-I/50.
154. Sun B, Krahl SE, Zhan S, Shen J: Improved capsulotomy for refractory Tourette's syndrome. Stereotact Funct Neurosurg 2005;83:55-56.
155. Ackermans L, Temel Y, Cath D, van der Linden C, Bruggeman R, Kleijer M, Nederveen P, Schruers K, Colle H, Tijssen MA, Visser-Vandewalle V: Deep brain stimulation in Tourette's syndrome: Two targets? Mov Disord 2006;21:709-713.
156. Houeto JL, Karachi C, Mallet L, Pillon B, Yelnik J, Mesnage V, Welter ML, Navarro S, Pelissolo A, Damier P, Pidoux B, Dormont D, Cornu P, Agid Y: Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry 2005;76:992-995.
157. Visser-Vandewalle V, Temel Y, Boon P, Vreeling F, Colle H, Hoogland G, Groenewegen HJ, van der Linden C: Chronic bilateral thalamic stimulation: A new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 2003;99:1094-1100.
158. Flaherty AW, Williams ZM, Amirnovin R, Kasper E, Rauch SL, Cosgrove GR, Eskandar EN: Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: Technical case report. Neurosurgery 2005;57(suppl):E403.
159. Leckman JF, Vaccarino FM, Kalanithi PS, Rothenberger A: Annotation: Tourette syndrome: A relentless drumbeat - driven by misguided brain oscillations. J Child Psychol Psychiatry 2006;47: 537-550.
160. Albin RL, Mink JW: Recent advances in Tourette syndrome research. Trends Neurosci 2006;29:175-182.
161. Butler T, Stern E, Silbersweig D: Functional neuroimaging of Tourette syndrome: Advances and future directions. Adv Neurol 2006;99:115-129.
162. Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J, Carson RE, Herscovitch P, Chase TN: The functional neuroanatomy of Tourette's syndrome: An FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 1993;9: 277-291.
163. Braun AR, Randolph C, Stoetter B, Mohr E, Cox C, Vladar K, Sexton R, Carson RE, Herscovitch P, Chase TN: The functional neuroanatomy of Tourette's syndrome: An FDG-PET study. II: Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology 1995;13:151-168.
164. Eidelberg D, Moeller JR, Antonini A, Kazumata K, Dhawan V, Budman C, Feigin A: The metabolic anatomy of Tourette's syndrome. Neurology 1997;48: 927-934.
165. Jeffries KJ, Schooler C, Schoenbach C, Herscovitch P, Chase TN, Braun AR: The functional neuroanatomy of Tourette's syndrome: An FDG PET study. III: Functional coupling of regional cerebral metabolic rates. Neuropsychopharmacology 2002;27: 92-104.
166. Stern E, Silbersweig DA, Chee KY, Holmes A, Robertson MM, Trimble M, Frith CD, Frackowiak RS, Dolan RJ: A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 2000;57: 741-748.
167. Lerner A, Bagic A, Boudreau EA, Hanakawa T, Pagan F, Mari Z, B ara-Jimenez W, Aksu M, Ga rraux G, Simmons JM, Sato S, Murphy DL, Hallett M: Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology 2007;68:1979-1987.
168. Sukhodolsky DG, Leckman JF, Rothenberger A, Scahill L: The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette
169. Biswal B, Ulmer JL, Krippendorf RL, Harsch HH, Daniels DL, Hyde JS, Haughton VM: Abnormal cerebral activation associated with a motor task in Tourette syndrome. AJNR Am J Neuroradiol 1998;19:1509-1512.
170. Serrien DJ, Nirkko AC, Loher TJ, Lovblad KO, Burgunder JM, Wiesendanger M: Movement control of manipulative tasks in patients with Gilles de la Tourette syndrome. Brain 2002;125:290-300.
171. Fattapposta F, Restuccia R, Colonnese C, Labruna L, Garreffa G, Bianco F: Gilles de la Tourette syndrome and voluntary movement: A functional MRI study. Psychiatry Res 2005;138:269-272.
172. Gates L, Clarke JR, Stokes A, Somorjai R, Jarmasz M, Vandorpe R, Dursun SM: Neuroanatomy of coprolalia in Tourette syndrome using functional magnetic resonance imaging. Prog Neuropsychopharmacol Biol Psychiatry 2004;28: 397-400.
173. Bohlhalter S, Goldfine A, Matteson S, Garraux G, Hanakawa T, Kansaku K, Wurzman R, Hallett M: Neural correlates of tic generation in Tourette syndrome: An event-related functional MRI study. Brain 2006;129:2029-2037.
174. Hershey T, Black KJ, Hartlein JM, Barch DM, Braver TS, Carl JL, Perlmutter JS: Cognitivepharmacologic functional magnetic resonance imaging in Tourette syndrome: A pilot study. Biol Psychiatry 2004;55:916-925.
175. Hershey T, Black KJ, Hartlein J, Braver TS, Barch DM, Carl JL, Perlmutter JS: Dopaminergic modulation of response inhibition: An fMRI study. Brain Res Cogn Brain Res 2004;20:438-448.
176. Marsh R, Zhu H, Wang Z, Skudlarski P, Peterson BS: A developmental fMRI study of self-regulatory control in Tourette's syndrome. Am J Psychiatry 2007;164:955-966.
177. Peterson B, Riddle MA, Cohen DJ, Katz LD, Smith JC, Hardin MT, Leckman JF: Reduced basal ganglia volumes in Tourette's syndrome using threedimensional reconstruction techniques from magnetic resonance images. Neurology 1993;43: 941-949.
178. Singer HS, Reiss AL, Brown JE, Aylward EH, Shih B, Chee E, Harris EL, Reader MJ, Chase GA, Bryan RN, et al: Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993;43:950-956.
179. Moriarty J, Varma AR, Stevens J, Fish M, Trimble MR, Robertson MM: A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 1997; 49:410-415.
180. Zimmerman AM, Abrams MT, Giuliano JD, Denckla MB, Singer HS: Subcortical volumes in girls with Tourette syndrome: Support for a gender effect. Neurology 2000;54:2224-2229.
181. Castellanos FX, Giedd JN, Hamburger SD, Marsh WL, Rapoport JL: Brain morphometry in Tourette's syndrome: The influence of comorbid attentiondeficit/hyperactivity disorder. Neurology 1996;47: 1581-1583.
182. Aylward EH, Reiss AL, Reader MJ, Singer HS, Brown JE, Denckla MB: Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996;11:112-115.
183. Hyde TM, Stacey ME, Coppola R, Handel SF, Rickler KC, Weinberger DR: Cerebral morphometric abnormalities in Tourette's syndrome: A quantitative MRI study of monozygotic twins. Neurology 1995;45:1176-1182.
184. Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang H, Bronen R, King RA, Leckman JF, Staib L: Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003;60:415-424.
185. Bloch MH, Leckman JF, Zhu H, Peterson BS: Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005;65:1253-1258.
186. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC: Subcortical MRI volumes in neurolepticnaive and treated patients with schizophrenia. Am J Psychiatry 1998;155:1711-1717.
187. Lee JS, Yoo SS, Cho SY, Ock SM, Lim MK, Panych LP: Abnormal thalamic volume in treatment-naive boys with Tourette syndrome. Acta Psychiatr Scand 2006;113:64-67.
188. Garraux G, Goldfine A, Bohlhalter S, Lerner A, Hanakawa T, Hallett M: Increased midbrain gray matter in Tourette's syndrome. Ann Neurol 2006; 59:381-385.
189. Ludolph AG, Juengling FD, Libal G, Ludolph AC, Fegert JM, Kassubek J: Grey-matter abnormalities in boys with Tourette syndrome: Magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry 2006;188:484-485.
190. Gorman DA, Zhu H, Anderson GM, Davies M, Peterson BS: Ferritin levels and their association with regional brain volumes in Tourette's syndrome. Am J Psychiatry 2006;163:1264-1272.
191. Konofal E, Lecendreux M, Arnulf I, Mouren MC: Iron deficiency in children with attentiondeficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2004;158:1113-1115.
192. Millichap JG, Yee MM, Davidson SI: Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2006;34:200-203.
193. Peterson BS, Leckman JF, Duncan JS, Wetzles R, Riddle MA, Hardin MT, Cohen DJ: Corpus callosum morphology from magnetic resonance images in Tourette's syndrome. Psychiatry Res 1994;55:85-99.
194. Baumgardner TL, Singer HS, Denckla MB, Rubin MA, Abrams MT, Colli MJ, Reiss AL: Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 1996;47:477-482.
195. Plessen KJ, Wentzel-Larsen T, Hugdahl K, Feineigle P, Klein J, Staib LH, Leckman JF, Bansal R, Peterson BS: Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry 2004;161:2028-2037.
196. Kates WR, Frederikse M, Mostofsky SH, Folley BS, Cooper K, Mazur-Hopkins P, Kofman O, Singer HS, Denckla MB, Pearlson GD, Kaufmann WE: MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res 2002;116:63-81.
197. Hong KE, Ock SM, Kang MH, Kim CE, Bae JN, Lim MK, Suh CH, Chung SJ, Cho SC, Lee JS: The segmented regional volumes of the cerebrum and cerebellum in boys with Tourette syndrome. J Korean Med Sci 2002;17:530-536.
198. Fredericksen KA, Cutting LE, Kates WR, Mostofsky SH, Singer HS, Cooper KL, Lanham DC, Denckla MB, Kaufmann WE: Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 2002;58:85-89.
199. Peterson BS, Staib L, Scahill L, Zhang H, Anderson C, Leckman JF, Cohen DJ, Gore JC, Albert J, Webster R: Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 2001;58:427-440.
200. Amat JA, Bronen RA, Saluja S, Sato N, Zhu H, Gorman DA, Royal J, Peterson BS: Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessivecompulsive disorder, and attention deficit hyperactivity disorder. Am J Psychiatry 2006;163:1106-1108.
201. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P: An international perspective on Tourette syndrome: Selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000;42:436-447.